NYSE · CON
Healthcare · Medical - Care Facilities
$35.16▼ 0.57% ($0.20)today
As of 3:04 PM ET
Market cap
$4.50B
P/E
22.68
EPS (TTM)
$1.55
Next earnings
Nov 5, 2026
Valuation
Verdict: fairly priced. Price above Base.
The price needs 2.3% free cash flow growth a year for 5 years. Our scenarios assume −21.5–8.5%.
Its past 4 years averaged −6.5% a year.
Value per share
Base case
$19.69
Price used $35.16 is 1.8× this
USD · TTM ending Jun 30, 2026 · Price Sep 29, 7:04 PM UTC
Reported total debt includes capitalised leases (~27% of the total). They are excluded from net debt and from the WACC weights because rent is already charged inside operating income. The Net Debt shown here is therefore lower than the balance-sheet figure elsewhere on this page.
Free cash flow each value needs
Free cash flow today $282M. The price needs $375M by 2036. Base case: $240M. At its recent pace: $144M. Bear to Bull: $100M to $534M.
$375M
What the price needs
2.3% a year for 5 yrs · by 2036
$144M
At its recent pace
−6.5% a year
+$136M
more free cash flow in 2036 than the Base case expects
$240M
Base case → $19.69/share
Free cash flow today $282M. The price needs $375M by 2036. Base case: $240M. At its recent pace: $144M. Bear to Bull: $100M to $534M.
Free cash flow in 2036
today $282M
+$136Mmore than the Base case · 1.6×
Value per share · Base case
$19.69
Price $35.16
1.8× this
Reported total debt includes capitalised leases (~27% of the total). They are excluded from net debt and from the WACC weights because rent is already charged inside operating income. The Net Debt shown here is therefore lower than the balance-sheet figure elsewhere on this page.
USD · TTM ending Jun 30, 2026 · Price Sep 29, 7:04 PM UTC
What each scenario assumes. Click a column to start from it.
Price vs Fundamentals
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
The stock rose 69.34% over the last year. Revenue grew 14.02% over the trailing twelve months. Operating margin moved from 15.71% to 16.39%. Free cash flow grew 87.13% over the trailing twelve months.
The stock move broadly lines up with stronger business momentum, and the shares are still only around the 50th percentile of their historical P/FCF range.
Operating margin is at 16.39%. Revenue grew 14.02% — this thesis depends on that trajectory holding. If revenue growth, margins, or free cash flow roll over while the stock keeps climbing, more of the move would be coming from multiple expansion than business progress.
Company profile
Concentra Group Holdings Parent, Inc. is a U.S.-based provider of occupational health solutions.
Market multiples
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
6
Buy
0
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 5, 2026
Q3 FY26 · EPS est $0.44 · Revenue est $605.23M
View
Concentra Group Holdings Parent, Inc. · CON
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.